+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ceftaroline"

From
Cephalosporin Drugs Market Report 2025 - Product Thumbnail Image

Cephalosporin Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Cephalosporin Drugs - Global Strategic Business Report - Product Thumbnail Image

Cephalosporin Drugs - Global Strategic Business Report

  • Report
  • February 2026
  • 398 Pages
  • Global
From
From
From
  • 5 Results (Page 1 of 1)
Loading Indicator

Ceftaroline is an antibiotic used to treat a variety of bacterial infections, including skin and soft tissue infections, community-acquired pneumonia, and complicated urinary tract infections. It is a cephalosporin antibiotic, which works by inhibiting the synthesis of bacterial cell walls. Ceftaroline is available in both intravenous and oral formulations, and is often used in combination with other antibiotics. Ceftaroline is a relatively new antibiotic, and is increasingly being used in clinical practice due to its broad spectrum of activity and good safety profile. It is particularly useful in treating infections caused by multi-drug resistant bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA). The ceftaroline market is highly competitive, with several major pharmaceutical companies offering the drug. These include Merck & Co., Pfizer, AstraZeneca, and Allergan. Show Less Read more